UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
AMSTERDAM, THE NETHERLANDS -- (Marketwire) -- 05/14/10 -- Eurand N.V. (NASDAQ: EURX) Recent Highlights: -- First quarter 2010 revenues grew to...
BETHESDA, MD -- (Marketwire) -- 05/03/10 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, has announced its national...
PHILADELPHIA, PA -- (Marketwire) -- 04/27/10 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today that John...
PHILADELPHIA, PA -- (Marketwire) -- 04/20/10 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today that...
AMSTERDAM, THE NETHERLANDS -- (Marketwire) -- 04/14/10 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, will host a...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 20-F ...
PHILADELPHIA, PA -- (Marketwire) -- 03/10/10 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today that it is...
AMSTERDAM, THE NETHERLANDS -- (Marketwire) -- 03/04/10 -- Eurand N.V. (NASDAQ: EURX) Recent Developments: -- Fourth quarter 2009 revenues were...
PHILADELPHIA, PA -- (Marketwire) -- 02/24/10 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today that it is...
PHILADELPHIA, PA -- (Marketwire) -- 02/16/10 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today the grant...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.